LKFT
Galapagos N.V. Sponsored ADR
NASDAQ · Healthcare · Biotechnology · US
$28.55
−1.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 47.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.75x
- PEG TTM
- —
- Price / book
- 0.50x
- Price / sales
- 1.64x
- Price / cash flow
- -8.45x
Enterprise value
- Enterprise value
- -$692.7M
- EV / sales
- -0.61x
- EV / EBITDA
- -1.11x
- EV / EBIT
- -0.99x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026